Skip to Main Content (Press Enter)

Logo UNIBS
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment

Expertise & Skills
Logo UNIBS

|

Expertise & Skills

unibs.it
  • ×
  • Home
  • People
  • Organizations
  • Expertise & Skills
  • Outputs
  • Jobs
  • Degrees
  • Courses
  • Third Mission
  • Equipment
  1. Outputs

Is precision medicine the solution to improve organ preservation in laryngeal/hypopharyngeal cancer? A position paper by the Preserve Research Group

Academic Article
Publication Date:
2024
Abstract:
In locally advanced (LA) laryngeal/hypopharyngeal squamous cell carcinoma (LHSCC), larynx preservation (LP) strategies aim at the cure of the disease while preserving a functional larynx, thus avoiding total laryngectomy and the associated impact on the quality of life. In the last decades, apart from transoral and open-neck organ preservation approaches, several non-surgical regimens have been investigated: radiotherapy alone, alternate, concurrent or sequential chemoradiation, and bioradiotherapy. Despite major progress, the identification of reliable and effective predictors for treatment response remains a clinical challenge. This review examines the current state of LP in LA-LHSCC and the need for predictive factors, highlighting the importance of the PRESERVE trial in addressing this gap. The PRESERVE trial represents a pivotal initiative aimed at finding the optimal therapy for laryngeal preservation specific to each patient through a retrospective analysis of data from previous LP trials and prospectively validating findings. The goal of the PRESERVE trial is to develop a comprehensive predictive classifier that integrates clinical, molecular, and multi-omics data, thereby enhancing the precision and efficacy of patient selection for LP protocols.
CRIS type:
1.1 Articolo in rivista
Keywords:
squamous cell carcinoma; larynx; hypopharynx; head and neck; chemotherapy; radiotherapy; organ preservation
List of contributors:
Mattavelli, D.; Wichmann, G.; Smussi, D.; Paderno, A.; Plana, M. S.; Mesia, R. N.; Compagnoni, M.; Medda, A.; Chiocca, S.; Calza, S.; Zhan, Y.; Rognoni, C.; Tarricone, R.; Stucchi, E.; Lorini, L.; Gurizzan, C.; Khelik, K.; Hovig, E.; Dietz, A.; Piazza, C.; Bossi, P.
Authors of the University:
CALZA STEFANO
MATTAVELLI DAVIDE
PIAZZA CESARE
Handle:
https://iris.unibs.it/handle/11379/611505
Published in:
FRONTIERS IN ONCOLOGY
Journal
  • Support
  • Privacy
  • Use of cookies
  • Legal notes

Powered by VIVO | Designed by Cineca | 26.11.1.0